Tectonic Therapeutics logo

Tectonic Therapeutics (TECX) Q4 2024 Annual Earnings

TECX·Reported March 20, 2025·Before market open

Diluted EPS came in at $-0.84, beat the $-1.39 consensus by $0.55.

Diluted EPS
$-0.84beat by $0.55
Consensus: $-1.39
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q4 2024

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q4 2024 Earnings FAQ

Common questions about Tectonic Therapeutics's Q4 2024 earnings report.

Tectonic Therapeutics (TECX) reported Q4 2024 earnings on March 20, 2025 before market open.

Tectonic Therapeutics reported diluted EPS of $-0.84 for Q4 2024.

EPS beat the consensus estimate of $-1.39 by $0.55.

You can read the 10-K periodic report (0000950170-25-042648) directly on SEC EDGAR. The filing index links above go to sec.gov.